| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269755 | HPB | 2011 | 7 Pages |
Abstract
Explant pathology can be used to predict the risk for recurrent HCC after LT, which may allow for improved adjuvant and management strategies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Nicholas N. Nissen, Vijay Menon, Catherine Bresee, Tram T. Tran, Alagappan Annamalai, Fred Poordad, Jeffrey H. Fair, Andrew S. Klein, Brendan Boland, Steven D. Colquhoun,